Wee Joo Chng

机构：National University of Singapore, National University Cancer Institute, Singapore, Michigan Cancer Research Consortium, Duke-NUS Medical School, National Cancer Institute, National Cancer Centre Singapore, National University Hospital, Clinical Research Consortium, National University Health System · ORCID：0000-0003-2578-8335

发表论文 985 篇 · 总被引 38021 次 · h-index 86

代表论文

• Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myeloma (2025 · Blood Cancer Journal · 被引 1)
• AI4Loop: an Artificial Intelligence Framework Reveals Increased 3D Chromatin Interactions and Therapeutic Vulnerabilities across 12,000 Cancer Samples (2026 · bioRxiv (Cold Spring Harbor Laboratory))
• International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas (2026 · Journal of Clinical Oncology)
• Abstract P48: MULTIMODAL DATA INTEGRATION FOR A PAN-CANCER ASIAN COHORT OF EXCEPTIONAL RESPONDERS AND HYPER-PROGRESSORS TO IMMUNOTHERAPY HIGHLIGHTS UTILITY OF BIOMARKERS (2026 · Cancer Research)
• Correction: Shyamsunder et al. THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors. Int. J. Mol. Sci. 2022, 23, 1207 (2026 · International Journal of Molecular Sciences)
• “MyeGPT: an AI agent for Multiple Myeloma” (2026 · medRxiv)